However, PD-L2 was significantly up-regulated on both breast cancer cell lines after normo- and hypofractionated RT which stresses that immune matrices should be followed up instead of focusing on one distinct ICM for screening [63]. This evidence concerns the gene PDCD1LG2 and breast carcinoma.